Filana Therapeutics, Inc. ( FLNA) - Stock Earnings
FLNA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -10.8 million USD | — USD |
| 2025Q4 | -12.5 million USD | — USD |
| 2026Q1 | -10.3 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
FLNA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -97.2 million USD | — USD |
| 2024 | -24.3 million USD | — USD |
| 2025 | -91.0 million USD | — USD |
| 2026 Est. | — | — |
FLNA
Price: $1.22
52 week price:
Earnings Per Share: -1.61 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 69.6 million